Technical Analysis for PULM - Pulmatrix, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 2.02 | 0.00% | 0.00 |
PULM closed unchanged on Wednesday, April 24, 2024, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: May 10
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 200 DMA Resistance | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.25% | |
| Wide Bands | Range Expansion | 0.25% |
| Alert | Time |
|---|---|
| Possible NR7 | about 10 hours ago |
| Up 1% | about 14 hours ago |
| 200 DMA Resistance | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Up 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company's proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease and other treatments. Pulmatrix, Inc. is based in Lexington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Clinical Development Rare Diseases Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Cystic Fibrosis Pulmonary Disease Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Clinical Development Rare Diseases Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Cystic Fibrosis Pulmonary Disease Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.14 |
| 52 Week Low | 1.55 |
| Average Volume | 15,612 |
| 200-Day Moving Average | 2.05 |
| 50-Day Moving Average | 1.86 |
| 20-Day Moving Average | 1.94 |
| 10-Day Moving Average | 2.06 |
| Average True Range | 0.12 |
| RSI (14) | 56.71 |
| ADX | 23.12 |
| +DI | 22.47 |
| -DI | 15.13 |
| Chandelier Exit (Long, 3 ATRs) | 1.82 |
| Chandelier Exit (Short, 3 ATRs) | 1.93 |
| Upper Bollinger Bands | 2.23 |
| Lower Bollinger Band | 1.64 |
| Percent B (%b) | 0.64 |
| BandWidth | 30.41 |
| MACD Line | 0.06 |
| MACD Signal Line | 0.06 |
| MACD Histogram | 0.0014 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.07 | ||||
| Resistance 3 (R3) | 2.07 | 2.06 | 2.06 | ||
| Resistance 2 (R2) | 2.06 | 2.05 | 2.06 | 2.06 | |
| Resistance 1 (R1) | 2.04 | 2.04 | 2.04 | 2.04 | 2.05 |
| Pivot Point | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 |
| Support 1 (S1) | 2.01 | 2.02 | 2.00 | 2.00 | 1.99 |
| Support 2 (S2) | 2.00 | 2.01 | 2.00 | 1.98 | |
| Support 3 (S3) | 1.98 | 2.00 | 1.98 | ||
| Support 4 (S4) | 1.97 |
